On Tuesday, GlycoMimetics Inc (NASDAQ: GLYC) opened lower -9.33% from the last session, before settling in for the closing price of $0.26. Price fluctuations for GLYC have ranged from $0.14 to $1.93 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -73.76% over the last five years. Company’s average yearly earnings per share was noted 96.61% at the time writing. With a float of $56.10 million, this company’s outstanding shares have now reached $64.48 million.
The firm has a total of 26 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
GlycoMimetics Inc (GLYC) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of GlycoMimetics Inc is 13.04%, while institutional ownership is 42.40%. The most recent insider transaction that took place on Aug 08 ’24, was worth 50,009. In this transaction 10% Owner of this company sold 260,873 shares at a rate of $0.19, taking the stock ownership to the 6,317,565 shares. Before that another transaction happened on Aug 07 ’24, when Company’s 10% Owner sold 61,488 for $0.18, making the entire transaction worth $11,197. This insider now owns 6,578,438 shares in total.
GlycoMimetics Inc (GLYC) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 96.61% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 62.95% during the next five years compared to 15.18% growth over the previous five years of trading.
GlycoMimetics Inc (NASDAQ: GLYC) Trading Performance Indicators
Check out the current performance indicators for GlycoMimetics Inc (GLYC). In the past quarter, the stock posted a quick ratio of 1.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.59, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -0.03 in one year’s time.
Technical Analysis of GlycoMimetics Inc (GLYC)
Analysing the last 5-days average volume posted by the [GlycoMimetics Inc, GLYC], we can find that recorded value of 1.22 million was better than the volume posted last year of 1.18 million. As of the previous 9 days, the stock’s Stochastic %D was 66.29%. Additionally, its Average True Range was 0.02.
During the past 100 days, GlycoMimetics Inc’s (GLYC) raw stochastic average was set at 32.97%, which indicates a significant decrease from 61.51% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 68.48% in the past 14 days, which was lower than the 88.93% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2472, while its 200-day Moving Average is $0.2451. Now, the first resistance to watch is $0.2558. This is followed by the second major resistance level at $0.2755. The third major resistance level sits at $0.2896. If the price goes on to break the first support level at $0.2220, it is likely to go to the next support level at $0.2079. Now, if the price goes above the second support level, the third support stands at $0.1882.
GlycoMimetics Inc (NASDAQ: GLYC) Key Stats
There are currently 64,514K shares outstanding in the company with a market cap of 15.24 million. Presently, the company’s annual sales total 0 K according to its annual income of -37,880 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -7,220 K.
